# OnCo record nct05955391 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05955391/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05955391", "NCT05955391" ;
  schema:name "TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)"@en ;
  schema:description "A phase 2 trial of TGRX-326 in non-small-cell lung cancer and small-cell lung cancer, run by Shenzhen TargetRx Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05955391/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05955391> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-01-18" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/alk-positive-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/tgrx-326/> ;
  onco:companies <https://onco.cc/companies/shenzhen-targetrx/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct05955391-j-thorac-oncol-2026/> .